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Abstract 
Sonodynamic therapy (SDT) relies on the ability of ultrasound to activate 
sonosensitisers and trigger the generation of reactive oxygen species (ROS) to achieve 
cell death. SDT was explored as an anticancer approach until 6 years ago, when its 
potential application as an antimicrobial strategy was pointed out and the term 
“sonoantimicrobial chemotherapy” (SACT) was coined. The excellent penetration of 
ultrasound in liquid media make SACT particularly promising approach for the non- 
invasive treatment of deep-seated infections, and for the reduction of bacterial load in 
turbid water. In this review we provide an account of the brief history of SACT, from 
its molecular bases to the current state of the art and perspective applications. 
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Introduction 
Over the last decades the insurgence of antibiotic-resistant microorganisms has 
become a pressing concern for public health as it represents the main cause for the 
failure of antibiotic therapy.1 The scientific community devoted great efforts to 
provide alternative solutions not  only to eradicate  infections in the  medical and 
veterinary setting, but also to reduce bacterial load in the context of environmental 
and industrial applications, since agricultural/environmental use of antibiotics plays a 
pivotal role in the spreading of resistance, through food-borne microorganisms2 and 
wastewater.3-5 In the quest for alternative approaches to microbial inactivation, 
physical methods (e.g., irradiation, heat, high pressure, etc.) gained popularity 
because they typically have less potential to induce resistance, and are amenable to 
application on large scale.6-8 Amongst these methods, ultrasonic waves have been 
explored as a bactericidal tool has been exploited since Harvey and Loomis provided 
the first evidence of the lethal effect of ultrasounds on microbes in 1929.9 Following 
their work, studies on ultrasound-mediated bacterial inactivation using a plethora of 
different experimental conditions (e.g., continued/pulsed waves, low/high intensity 
wave, type of ultrasound generators, etc.) were published, often reporting conflicting 
results. Nevertheless, some general traits emerged, such as the higher susceptibility of 
Gram-positive vs. Gram-negative bacteria, of rod-shaped bacteria vs. cocci, and of 
larger vs. smaller bacteria.10 It was shown that ultrasounds interfere with the life cycle 
of both planktonic11, 12 and biofilm13 bacteria, but again, depending on the microbe 
and the irradiation conditions, the outcome can be that of cell replication inhibition, 
cell inactivation, but also of stimulation of microbes vitality.14 
Ultrasound-mediated microbial inactivation eventually made its way into applications 
in medicine and industrial processes. Sonication, both stand-alone and associated with 
heath or high pressure, has been successfully employed to reduce the bacterial load in 
foodstuff with no detrimental effect on the quality of the treated food.15-17 In the 
medical field, ultrasound-based scalers are employed in dentistry for plaque 
removal,18 to promote the microbial uptake and/or the release of antibiotic (e.g., 
vancomycin, gentamicin) from prosthetic implants.19, 20 
Until a few years ago, the paths of antimicrobial photodynamic therapy and 
ultrasound waves hardly crossed. The synergy of ultrasounds and PACT was explored 
as a way to enhance the efficacy of photodynamic treatment in the disinfection of 
infected wounds,21, 22 and in a combined photodynamic/ultrasound treatment to 
eliminate dental plaque.23 High-frequency ultrasound was also employed to assess the 
efficacy of PACT in vitro.24 While these works were presenting light and ultrasound 
as the physical triggers of different biological effects (i.e., microbe inactivation and 
enhanced cell uptake or imaging, respectively), evidences coming from the field of 
anticancer therapy were showing that in the presence of photosensitisers, ultrasound 
and light could trigger similar events and elicit similar biological responses.25 These 
evidences cast the bases of a new anticancer approach named of sonodynamic therapy 
(SDT), which few years ago crossed the borders to enter the field of antimicrobial 
therapy. The aim of this review is to give an account of the state of the art of 
antimicrobial SDT, and an overview of the molecular bases of its mechanism of 
action. 
 
Figure 1: Simplified diagram of the ultrasound frequencies used for therapeutic 
applications26 
 
Ultrasound in living systems 
Ultrasound is an acoustic radiation inaudible to humans, with a frequency exceeding 
20 kHz. Ultrasound generates a mechanical vibration characterized by repeated cycles 
of compression and expansion in the surrounding environment.27 The ability of 
ultrasound to propagate through tissue and induce transient or permanent changes to 
biomolecules and cells has been successfully exploited for numerous biomedical 
applications, including therapeutic intervention (tissue repair, thrombolysis, 
angioplasty, drug delivery, endodontic disinfection, etc.) and diagnostic techniques.26 
(Figure 1). Modern ultrasound generators for biomedical applications rely on 
piezoelectric devices to produce a focused ultrasound beam that can be delivered to 
the target body district through the skin and underlying tissues. The ultrasound 
frequency range employed for diagnostic purposes is rather broad (2.0-28.0 MHz), 
whereas therapeutic applications are typically carried out with waves within the 0.5- 
3.0 MHz frequency range.27 Ultrasound-based diagnostic techniques rely on low- 
energy irradiation to avoid damaging cells/tissues, whereas therapeutic intervention 
require the delivery of higher doses of energy to generate the desired biological 
outcome.28 
The interactions of ultrasounds with living systems occur via three main pathways, 
namely, thermal (i.e., heat generation), chemical (i.e., radical formation) and 
mechanical (i.e., shear stress, liquid jets, shock wave), each of which triggers specific 
effects. The thermal effects are the desired outcome of most ultrasound-based 
therapeutic applications, as it happens, for example, in the high-intensity focused 
ultrasound (HIFU) therapy of cancer, where an ultrasound beam focused on the target 
malignancy delivers a dose of energy that causes a spatially-confined hyperthermic 
effect and subsequent coagulative necrosis at the focal point.29 The mechanical effects 
of ultrasounds causes transient alterations of the permeability of cell membrane, a 
phenomenon that underpins the enhanced cell uptake of both low- and high-molecular 
weight drugs observed upon exposure to ultrasound.30 The phospholipidic membrane 
is intrinsically able of absorbing the mechanical energy generated by the sonic wave, 
and of responding with deformations (compressions and expansions) of the 
intramembrane space: this behaviour has been advantageously exploited in the 
ultrasound-mediated drug targeting and controlled drug release in several therapeutic 
fields.31    The  chemical  effects  of  ultrasound  are  associated  to  the  onset  of 
sonochemical reactions (e.g., ionisation, electron-transfer), and/or the sonolytic 
formation of free radicals: these processes have a great potential for therapeutic 
applications, but due to the short-life of the species generated, they are very 
challenging to harness. 
It is  generally agreed  that the  effects of  ultrasounds in  tissues  originate from  a 
phenomenon known as acoustic cavitation. The action of ultrasound waves 
propagating in a liquid promotes the formation of gas- or vapour-filled cavities 
(microbubbles), which undergo shrinking and growing cycles due to the alternate 
compression and expansion generated by the different pressure phases of the 
ultrasound wave. Low-amplitude oscillation of the microbubbles leads to stable 
cavitation (non-inertial), in which the microbubble “pulsates”  generating 
microstreams in the surrounding medium, causing shear stress to cell membranes and 
eventually resulting in the transient formation of pores (sonoporation). (Figure 2, A). 
High-amplitude oscillations of the microbubble give rise to inertial cavitation, in 
which the alternating shrinking and expansion increase in intensity until the 
microbubble implodes. Collapsing microbubbles results in the generation of shock 
waves and/or liquid jet formation, the force of can easily perforate cell membranes. 
(Figure 2, B and C). 
 
            
Figure 2: Membrane damages following acoustic cavitation. 
 
Sensitised living systems to ultrasound: sonodynamic therapy and its molecular 
bases 
A peculiar effect of ultrasound is its ability to induce transient but dramatic changes 
to the physicochemical behaviour of given molecular species (sensitisers), and trigger 
localised  chain  of  events  culminating  in  alterations  to  subcellular  structures  and
eventually cell damage and death. Following the same rational that led to translate the 
sensitisation to light into photodynamic therapy, the possibility of sensitising cells to 
ultrasound received a great attention as a potential warhead for an innovative 
therapeutic approach that gained the name of sonodynamic therapy (SDT). 
As the photodynamic process, sonodynamic treatment relies on two per se harmless 
components, i.e., a sensitiser and ultrasound. Irradiation of the sensitiser with 
ultrasound initiates a chain of events that culminates with the production of highly 
reactive cytotoxic species, rapidly leading to cell death via apoptosis and/or necrosis 
and/or autophagy.32 The potential of this approach for the reduction of solid tumours 
has been intensely investigated, and its efficacy has already been demonstrated at the 
preclinical level on some experimental tumour models. A crucial difference between 
PDT and STD arises from the different power of penetration of the activating 
radiation: while light has a relatively limited reach within tissue, ultrasound easily 
propagates through it, allowing to target more deeply-seated lesions without the need 
of invasive devices such as implanted fibre-optic.33 
The binary nature of the treatment is not the only similar trait of SDT and PDT: as for 
the photodynamic process, ultrasound activation of the sensitiser results in the 
localised production of ROS. An indirect confirmation of this instance is the fact that 
the majority of the molecules that are able to sensitise cells to ultrasound are also 
photosensitisers; porphyrins and related tetrapyrroles, rose Bengal, and ALA, to cite a 
few examples, displayed sonodynamic efficacy in a number of studies.34 Although the 
exact mechanism of SDT has not been entirely elucidated, it is generally accepted that 
the main effectors of the sonosensitised cell damage are short-lived species, namely 
ROS and free radicals, generated as a consequence of inertial acoustic cavitation.35 
(Figure 3). When the acoustic pressure amplitude is sufficiently high, the cavitation 
microbubbles implode violently and a dramatic increase of temperature and pressure 
occurs. It has been estimated that on a nanosecond time scale the collapse of the 
microbubble can induce spikes of temperatures reaching 5000 K and pressures of 250 
MPa.36 In these “hot spots” confined to the vicinity of the microbubbles, the high 
liquid shear-forces, the shock waves, and the localized heating, promote sonochemical 
reactions (sonolysis), and light emission (sonoluminescence).37 Two hypotheses were 
formulated to explain ROS generation from acoustic cavitation; one of them suggests 
that the high energy released by the collapsing microbubble promotes the sonolysis of 
water molecules and/or of the sensitiser molecules: the radicals formed can then react 
with oxygen, triggering the production of reactive oxygen species. The second 
hypothesis explains the generation of radical on the basis of sonoluminescence, a 
radiation emitted by excited molecules formed by the recombination of radicals 
generated from the collapsing microbubble.38 In the vicinity of the collapsing 
microbubble, the light emitted can be absorbed by the sensitiser, triggering a purely 
photodynamic process which can evolve either into a Type I process, again leading to 
the formation of radicals, or in a Type II process, with singlet oxygen as the main 
effector.
          
Evidences supporting the generation of radicals, oxygen radicals and singlet oxygen 
by either one of these two pathways have been provided in several works.25, 38, 39 In 
eukaryotic cells it has been shown that the nature of the damages caused by the 
sonodynamic process involves alterations to the cytoskeleton,40 extensive membrane 
perturbations,41 and Bcl-2 gene family down-regulation and consequent mitochondria 
outer membrane permeabilisation, leading to the release of caspase activators (e.g., 
cytochrome c) or other proapoptotic molecules including apoptosis-inducing factors 
(AIF).42, 43 
SACT: sensitizing microbes to ultrasound 
In the 90s, Tachibana et al.44 and Umemura et al.39 showed that ultrasound was able 
to activate photosensitizer to kill cancer cells. Following that work, the research in the 
field of SDT of the last 20 years has focused primarily on anticancer treatment.34 
Recently, Ma et al. suggested that sonodynamic therapy may be exploited for the 
eradication of microbial infections.45 In analogy with the concept of PACT, 
sonodynamic antimicrobial chemotherapy (SACT) was proposed as a therapeutic 
modality where a sonosensitiser is selectively delivered to target microbial cells and 
activated by ultrasound to induce the cell death.46 In the last five years the few groups 
active in this area achieved ultrasound mediated inactivation of different kind of 
bacteria with various sensitisers, including fluoroquinolone antibiotics, “classic” 
photosensitisers, and TiO2.47, 48 
Antibiotic-mediated SACT 
The observation that ultrasounds enhances the activity of antibiotics was first reported 
by Liu et al.,49 who studied the sonodynamic antibacterial effect of two 
fluoroquinolones (ciprofloxacin and levofloxacin) on E. coli. Ultrasound irradiation of 
a 104 CFU/mL bacterial population for 45 min achieved a 2-log reduction of the 
microbial load, although the bacterial inactivation following fluoroquinolone-SACT 
treatment is less than 10 times higher than the one achieved by the antibiotic alone. 
(Table 1, Entry 1). The authors show the involvement of ROS by trapping oxygen 
radicals with a chemical trap. 
In another study, the efficacy of gentamycin in association with pulsed ultrasounds in 
preventing the formation of E. coli biofilms in bone cement in vivo (rabbit model) 
was evaluated.50 (Table 1, Entry 2) Although the authors do not rationalise the results 
on the basis of the sonodynamic action, their experiments show that the application of 
ultrasound (28 to 48 kHz, 0.5 W/cm2, 48 h) reduces the population of 109 CFU/mL of 
biofilm bacteria by 2 log on gentamycin-loaded poly-acrylic bone cement implant in 
rabbit legs. 
SACT mediated by photosensitisers 
The Nisnevitch group studied the effect of 28 kHz ultrasound irradiation on Gram- 
negative E. coli and Gram-positive S. aureus in the presence of Rose Bengal and 
methylene blue as sonosensitisers.51 Following on from their previous studies on the 
photodynamic inactivation of microorganisms exploiting the chemiluminescent 
oxidation of luminol as the light source,52 the authors focus on the ultrasound 
radiation as the initiator of dye-sensitised cell damage. When E. coli cells were 
incubated with rose Bengal (0-15 µM, 15 min) and subsequently exposed to 
ultrasound irradiation in the dark (to avoid the photodynamic activation of the 
sensitiser) a reduction of up to 3-log in the bacterial population was observed (initial 
load: 109 CFU/mL). (Table 1, Entry 3). The effect of sonication alone had little effect 
on the vitality of microbes on a 107 CFU/mL cell population, but caused a 2-log 
reduction in a denser E. coli population (109 CFU/mL). The highest eradication rate 
for E. coli was observed when a 106 CFU/mL population was incubated with 15 𝜇M 
RB (4.2 log). S. aureus proved less susceptible to ultrasound irradiation alone, in 
agreement with previous evidences, but intriguingly it was more susceptible to the 
exposure to the sensitiser alone than E. coli. SACT treatment of S. aureus, consisting 
in the irradiation of a 106 CFU/mL following incubation with 15 𝜇M RB, achieved a 
5.5  log  reduction  in  the  bacterial  load.  Surprisingly,  this  study  showed  that  the 
efficacy of MB as a SACT sensitiser is negligible. Irradiation of a 106 CFU/mL cell 
population of S. aureus (28 kHz, 0.84 W/cm2, 1 h) following incubation with 30 𝜇M  
MB caused a negligible reduction in cell vitality, in sharp contrast with the  results 
obtained following photodynamic activation of the sensitiser (white light, 1.6 
mW/cm2, 0.5 h), which afforded a complete eradication of the microorganisms. The 
authors explain this unexpected behaviour by considering that although 
sonoluminescence has a broad emission width, its maximum intensity lies between 
250 and 600 nm, offering a minimal overlap with the absorption profile of MB (500- 
700, λmax > 650 nm). 
Wang et al. investigated the efficacy of sonodynamic inactivation of planktonic 
methicillin-resistant S. aureus, using curcumin as the sonosensitiser.53 5 min of 1 
MHz US irradiation at a fluence rate of 1.6 W/cm2 achieved a reduction of 5 log in 
the microbial load. (Table 1, Entry 4). At the dose used in this study (40 µM) 
curcumin showed no toxicity without irradiation, and similarly exposure to ultrasound 
did not have intrinsic bactericidal effect. The authors also performed studies to 
investigate whether curcumin-mediated sonodynamic cell inactivation involved 
damages to bacterial DNA: pulsed-field electrophoresis showed that the profile of 
bacterial DNA following SACT treatment was substantially the same as that of the 
control cells. 
Zhou and co-workers studied the effect of hematoporphyrin monomethyl ester 
(HMME) in the SACT of S. aureus.54 The authors investigated the effect of the 
sensitiser dose and the ultrasound dose on the cell inactivation efficacy, and they 
found that under the most effective SACT parameters, which involved the incubation 
with 50 µg/L HMME followed by US irradiation (1 MHz, 6 W/cm2, 30 min), the 
reduction in microbial load was ca. 2 log. (Table 1, Entry 5). 
TiO2-mediated SACT for wastewater disinfection 
The sonodynamic treatment is under study as an alternative approach for water 
disinfection. While the efficacy of stand-alone ultrasound irradiation for water 
disinfection has been proven, the feasibility of this approach require the use of high- 
intensity radiation to achieve high-log reduction of the microbial load. It has been 
suggested that the sonodynamic treatment could overcome this limitation: the synergy 
between sonosensitisers and ultrasound radiation could result in a more efficient cell 
inactivation, allowing to use less intense irradiation and consequently encourage the 
application of this treatment on a larger scale.* 
The sensitiser proposed for the SACT-mediated disinfection of water is titanium 
dioxide. It has been postulated that under ultrasonic irradiation excited electrons move 
from the valence band to the conduction band, generating positive holes in  the 
valence band. In the proximity of the surface of TiO2 electrons are abstracted from 
water molecules to generate hydroxyl radicals, which are plausible effectors of the 
cell damage that results in microbial inactivation. Drakopoulou et al.55 showed that 60 
minutes irradiation with 24 kHz ultrasound (total ultrasound dose 5400 kJ/L) achieves 
up to 2-log reduction in the population of Gram-negative bacteria (coliforms and 
Pseudomonas spp.) in wastewater obtained from the outlet of an activated sludge 
process. (Table 1, Entry 6). The authors studied the microbial reduction of 4 bacteria 
groups (total coliformis, faecal coliformis, Pseudomonas spp., and faecal 
streptococci) and C. perfringens. This study provides yet another evidence that Gram- 
positive bacteria display a lower susceptibility to the sonodynamic treatment. 
In a different study, ultrasound irradiation in the presence of 1.0 g/mL of TiO2 caused 
a 3-log load reduction of Legionella spp. in wastewater. Variation in the initial 
bacterial load of the water (from 8.0x102 to 7.3x107 CFU/mL) did not seem to affect 
the efficacy of the treatment.56 (Table 1, Entry 7). The authors demonstrated that the 
presence of ROS scavengers  (e.g., glutathione, histidine and  ascorbic acid) 
dramatically reduces the efficacy of the bacterial inactivation, indicating the 
involvement of ROS in the process. The authors argue that SACT is better suited to 
the disinfection of wastewater thanks to the penetration power of ultrasounds, which, 
unlike light, is not affected by the turbidity of the medium. 
Rahman et al. explored the efficacy of a non-woven TiO2 fabric as a sonosensitiser 
for the disinfection of water contaminated with E. coli.57 When a colony of 108 
CFU/mL was exposed to 36 kHz ultrasound radiation (0.28 W, up to 1h) in the 
presence of non-woven TiO2, a cell inactivation of ca. 1 log was observed. The 
authors proved that lipid peroxidation underpins the SACT inactivation of E. coli by 
performing the experiments in the presence of a fluorescent indicator (DPPP), whose 
emission intensity increases in the presence of peroxidative chain reactions. 
Furthermore, the authors demonstrated that in the presence of ROS scavengers 
(glutathione or tert-butanol) the fluorescence emission from the reporter dye was 
considerably reduced, indicating the involvement of ROS as the cell-damage 
effectors. 
 
 
 
Entry	  
 
 
Sonosensitiser	  
 
 
Dose	  
 
Irradiation	  
conditions	  
 
 
Microorganism(s)	  
Initial	  
load	  
(CFU/mL)	  
Microbial	  
load	  
reduction	  
(log)	  
 
 
Ref.	  
1 
ciprofloxacin/ 
levofloxacin 
0.01 
mg/mL 
40 kHz, 1 
W/cm2 
E. coli 104 < 2 
 
49 
2 gentamycin -* 
28 to 48 kHz, 
0.5 W/cm2, 48 h 
E. coli 109 2 
 
50 
3 rose Bengal 
0-15 
µM 
28 kHz, 0.84 
W/cm2, 1-2 h 
S. aureus, E. coli 109 2-3 51 
4 curcumin 40 µM 
1 MHz, 1.56 
W/cm2, 5 min 
MRSA 107 5 
 
53 
5 HMME 
10-50 
µg/L 
1 MHz, 6 
W/cm2, 30 min 
S. aureus 108 < 2 
 
54 
 
 
6 
 
TiO2 
(21 nm ø 
nanoparticles) 
 
5 
mg/mL 
 
24 kHz, 300W, 
15-60 min 
Pseudomonas spp. 
faecal coliformis 
total coliformis 
faecal streptococci 
C. perfringens 
 
 
< 105 
 
 
2 
 
 
 
55 
7 
TiO2 
(2 mm ø pellets) 
1 
mg/mL 
36 kHz, 300W, 
15-60 min 
Legionella spp. 103 < 2 
 
56 
8 
TiO2 non- 
woven fabric - 
36 kHz, 0.28W, 
0-70 min 
E. coli 108 1 
 
57 
 
Conclusions 
SACT is a relatively new antimicrobial approach, and unlike in the case of anticancer 
SDT, the works published in the field are few and far between. The studies surveyed 
in this review represent, to the best of our knowledge, the complete heritage our 
knowledge in the field of SACT. The experimental conditions examined differ to such 
an extent that little margin is left for the comparison and rationalisation of the results. 
If SACT is to be translated into an antimicrobial tool for biomedical or environmental 
applications, much remains to be explored to further our understanding of the field: 
the large body of work devoted to the establishment of SACT’s older sibling (PACT) 
should encourage the scientific community to work towards the full elucidation of the 
mechanistic bases of the sonodynamic process and towards the understanding of the 
pathways that lead to cell death so that they can both be harnessed to enhance the 
efficacy of the approach. Insofar, SACT has been explored for the inactivation of 
bacteria:  the  sonodynamic  process  possesses  the  same  trait  of  generality  as  the 
photodynamic, and it is reasonable to expect that other microorganisms are sensitive 
to  the  treatment,  but  SACT  treatment  on  viruses,  fungi,  or  yeasts  has  not  been 
reported yet. Systematic studies on the effect of the various parameters of the sonic 
wave (continuous or pulsed wave, frequency and intensity, energy delivered, etc.) 
have not been reported, as, crucially, the selectivity of the sonodynamic treatment for 
microbes  vs.  host  cells,  a  factor  of  paramount  importance  for  any  therapeutic 
application of SDT, remains totally unexplored. Investigations on the possibility of 
the onset of resistance to SACT should also be undertaken. 
While the published data might not suggest that SACT is on the verge of becoming 
the next panacea for clinical antimicrobial therapy, the studies carried out show that 
sonosensitisation of microorganisms is well worth investing in, especially for 
environmental applications: the relatively low prices of ultrasound generators and 
TiO2-based sonosensitiser, together with the suitability of the technique for the 
disinfection of turbid water on a large scale, makes SACT suitable for wastewater 
treatment. SACT disinfection of implants pre-loaded with sonosensitiser also seems a 
promising application, because it would offer an attractive alternative to systemic 
antibiotic administration: in addition, the excellent penetration of ultrasound radiation 
in tissues would allow the eradication of microbial infections on deep-seated implants 
without the need of invasive devices to deliver the activating radiation. 
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ALA 5-aminolaevulinic acid 
CFU colony-forming units 
DPPP diphenyl-1-pyrenylphosphine 
HMME haematoporphyrin monomethylester 
MB methylene blue 
PACT photodynamic antimicrobial chemistry 
PDT photodynamic chemistry 
PpIX protoporphyrin IX 
RB rose Bengal 
ROS reactive oxygen species 
SACT sonodynamic antimicrobial chemotherapy 
SDT sonodynamic chemistry 
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